MiR-let-7e is an essential constituent of the lncRNA SNHG4/let-7e/KDM3A/p21 pathway, which has been related to NSCLC development and is possibly one of the vital therapeutic targets for NSCLC [239]. This evidence concerns the gene KDM3A and non-small cell lung carcinoma.